Back to search results

Improving Medication Use for Breast Cancer Survivors

This study is testing a new integrated medication monitoring (MM) system to help breast cancer survivors take their endocrine therapy as prescribed. The system includes surveys, a smartphone app (Digital Trails based on the UVA Sensus app), a wireless medication event monitor (Wisepill), and a wearable sensor (Fitbit). The main goal is to see if using this system over six months improves how well survivors stick to their medication schedule. You might be able to join if you are a woman between 21 and 70, speak English, were diagnosed with early-stage breast cancer (Stage 0-3) in the last five years, have finished most treatments except endocrine therapy, and are currently prescribed endocrine therapy. The study plans to enroll 15 participants.

Study design
This is a single-arm study, meaning all 15 participants will receive the same intervention. The study will collect data over a six-month period.
What's involved
You would use a smartphone app, a wireless medication event monitor, and a wearable sensor daily. You would also complete surveys at the beginning, 3 months, and 6 months, and answer smartphone-based questions every few days, weekly, and monthly.
Compensation
Not stated in the trial record.
Follow-up
Data collection will occur from enrollment to the end of the study at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06865755

Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication

Not Yet Recruiting
NAAges 21–70InterventionalSupportive care
San Diego State University
~15 participants
Updated 2026-04-27 on ClinicalTrials.gov
What's tested:integrated medication monitoring (MM) system

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Wisepill MEMS Sensor data collection
Measured over From enrollment to the end of study at 6 months
+25 more outcomes measured

Conditions

Breast Cancer Survivor
Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
California1

Who to contact

Kristen J Wells, PhD
[email protected]
619-594-1919
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

are English-speaking and reading;
are between ages 21 and 70 years;
are diagnosed with stage 0-3 breast cancer in the past 5 years;
have completed all surgery, radiation, and chemotherapy, except endocrine therapy;
are prescribed endocrine therapy;
do not have a physical impairment that would prevent them from using the MM system;
are able to provide informed consent;
are willing and able to use the MM system for 6 months;
have an Iphone or Android phone.

What this trial measures

  • Wisepill MEMS Sensor data collectionFrom enrollment to the end of study at 6 months

    Participants will be asked to put their endocrine therapy medication in the Wisepill device and will be asked to open the Wisepill when taking their medicine daily for six months

  • Intervention component - Introduction6 months after enrollment into study

    Number of respondents who reported receiving and/or using the app introduction

  • Intervention component - Instructions6 months after enrollment into the study

    Number of respondents who reported receiving and/or using instructions for using the app

  • Intervention component - calendar6 months after enrollment into the study

    Number of respondents who reported receiving and/or using the app calendar

  • Intervention component - resources6 months after enrollment into the study

    Number of respondents who reported receiving and/or using resources for breast cancer survivors

  • Intervention component - relaxation audio files6 months after enrollment into the study

    Number of respondents who reported receiving and/or using relaxation audio files

  • Intervention component - social support6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about social support

  • Intervention component - tamoxifen6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about tamoxifen

  • Intervention component - aromatase inhibitors6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about aromatase inhibitors

  • Intervention component - routine6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about establishing a routine for taking medications

  • Intervention component - reminders6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about setting medication reminders

  • Intervention component - joint pain6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about managing joint pain

  • Intervention component - hot flashes6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about managing hot flashes

  • Intervention component - pacing6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about pacing

  • Intervention component - relaxation6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about relaxation

  • Intervention component - needs6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about getting what they need from their health care providers

  • Intervention component - travel6 months after enrollment into the study

    Number of respondents who reported receiving and/or using information about travel

  • Intervention component - thoughts6 months after enrollment into the study

    Participants will be asked to describe what they thought about the intervention overall (qualitative response)

  • Intervention component - most useful6 months after enrollment into the study

    Participants will be asked to describe the most useful intervention components (qualitative response)

  • Intervention component - least useful6 months after enrollment into the study

    Participants will be asked to describe the least useful intervention components (qualitative response)

  • Intervention component - most attractive6 months after enrollment into the study

    Participants will be asked to describe which intervention components were most attractive (qualitative response)

  • Intervention component - least attractive6 months after enrollment into the study

    Participants will be asked to describe which intervention components were least attractive (qualitative response)

  • Intervention component - problems6 months after enrollment into the study

    Participants will be asked to describe problems they experienced using the intervention application (qualitative response)

  • Intervention component - changes6 months after enrollment into the study

    Participants will be asked to describe any changes they would make to the intervention (qualitative response)

  • Intervention component - additional information6 months after enrollment into the study

    Participants will be asked to describe what additional information the intervention should provide (qualitative response)

  • Intervention component - future use6 months after enrollment into the study

    Participants will be asked to describe whether or not they would be willing to use the intervention and monitoring system in the future to remember to take medicines.